8:00 - 8:45 a.m. |
Breakfast and CME Session: Optimal Preparation and Treatment Endpoints in cTACE (200)
Breakfast will be provided. Following the overview, participants will engage in hands-on learning at workstations supervised by expert faculty
- Overview, Michael C. Soulen, MD, FSIR, FCIRSE, University of Pennsylvania
Faculty: Nicholas Fidelman, MD, University of California San Francisco; Irene Bargellini, MD, Candiolo Cancer Institute and University of Turin; Nishita Kothary, MD, Stanford School of Medicine; Juan Martin Gimenez, MD, Ocshner Health; William Rilling, MD, FSIR, Medical College of Wisconsin; Tyler Sandow, MD, Ocshner Health; Vijay Ramalingam, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School; Nadine Abi-Jaoudeh, MD, University of California Irvine
|
9:00 a.m. - 5:00 p.m. |
Exhibit Hall Open |
9:00 - 10:00 a.m. |
IO Essentials: Sponsored Content presented by AstraZeneca (100)
|
BCLC C HCC Debate "Who's on First?" (200)
Moderators: Riad Salem, MD, MBA, Northwestern; Roberto Iezzi, MD, FCIRSE, Policlinico A Gemelli - IRCCS - Università Cattolica
- Lobar or Sublobar Portal Vein Invasion, Gregory Nadolksi, MD, University of Pennsylvania and Amit Singal, MD, UT Southwestern Medical Center
- Bilobar or Main Portal Vein Invasion, Daniel Sze, MD, PhD, Stanford University and Marina Baretti, MD, Johns Hopkins School of Medicine
- Patients with Vascular Invasion and Regional Metastases, Guy Johnson, MD, PharmD, University of Washington and Richard S. Finn, MD, Geffen School of Medicine at UCLA
|
Robotics, Navigation, Guidance, and Confirmation (200)
Moderators: Bruno C. Odisio, MD, PhD, FSIR, MD Anderson Cancer Center; Nadine Abi-Jaoudeh, MD, University of California Irvine
- Augmented Reality, Terence P. Gade, MD, PhD, University of Pennsylvania
- Technical Principles of Navigation, Iwan Paolucci, PhD, D Anderson Cancer Center
- Procedure Planning and Guidance, Nadine Abi-Jaoudeh, MD, University of California Irvine
- Robotics, Luigi A.Solbiati, MD, Humanitas University and Research Hospital
- Confirmation, Bruno C. Odisio, MD, PhD, FSIR, MD Anderson Cancer Center
|
10:00 - 10:30 a.m. |
Exhibit Hall Coffee Break |
Discovery Theatre Programming
- Internet: Friend or Foe? (All levels)
- Moderator: Julius Chapiro, MD, PhD, Yale University School of Medicine
- Faculty: Dianne Keen, FRMBA, AbbaDox; Nadine Abi-Jaoudeh, MD, University of California Irvine
|
10:30 - 11:30 a.m. |
Scientific Oral Abstracts (200)
Moderators: Isabel Gala Newton, MD, PhD, VASDMC and UCSD; Brad J. Wood, MD, NIH NCI NIBIB
|
Y90 Clinical Applications (200)
Moderators: Charles Y. Kim, MD, Duke University; Robert Lewandowski, MD, FSIR; Northwestern Medicine
- Strategies for Diffuse Bilobar Disease, Charles Y. Kim, MD, Duke University
- Approach to Challenging Patients, Thomas Helmberger, MD, PhD, Munich Klinik Bogenhausen
- Extra-hepatic Applications, Robert Lewandowski, MD, FSIR; Northwestern Medicine
- Holmium-166 and the RALLY Study, Marnix Lam, MD, PhD, University Medical Center Utrecht
|
11:30 a.m. - 1:00 p.m. |
Exhibit Hall Open
|
11: 45 a.m. - 12:30 p.m. |
Lunch and Industry Symposium
|
Lunch and Industry Symposium presented by Guerbet |
12:15 - 1:00 p.m. |
Discovery Theatre Programming
- 12:15 - 12:45 p.m. - Industry Abstract Presentations (All levels)
- Moderator: Isabel Gala Newton, MD, PhD, VASDMC and UCSD
- 12:45 - 1:00 p.m. - Product Theatre
|
1:00 - 2:30 p.m. |
Future Liver Remnant (200)
Moderator: Peiman Habibollahi, MD, MD Anderson Cancer Center; Nishita Kothary, MD, Stanford School of Medicine
- Surgical Techniques and Estimation of Functional Liver Reserve, Eric Nakakura, MD, PHD, University of California San Francisco
- PVE: Which Embolic to Choose? Jose Hugo Luz, MD, PhD, SOBRICE, FCIRSE, INCA Brazilian National Cancer Institute
- Total Venous Deprivation, Francesco de Cobelli, MD, San Raffaele Hospital and Salute University
- Radiation Lobectomy: Updates and Trials in Progress, Resmi Charalel, MD, MPH, Weill Cornell Medicine
|
MSK Tumor Board (200)
Moderators: Afshin Gangi, MD, PhD, University Hospital Strasbourg, King’s College London; Brandon M. Key, MD, Medical College of Wisconsin
- Pathalogic Fractures: IR Approach, Steven Yevich, MD, MPH, MD Anderson Cancer Center
- Pathalogic Fractures: Orthopedic Approach, Melissa Zimel, MD, University of California San Francisco
- Ablation and Vertebral Augmentation: Neuroprotective Techniques, Jack Jennings, MD, PhD, FACR, FSIR, FCIRSE, Washington University
- Electrochemotherapy, Frederic Deschampes, MD, PhD, Gustave Roussy
- Tumor Board, All session faculty listed above, Christian Meyer, MD, PhD, Johns Hopkins Hospital
|
Robotics, Navigation, Guidance, and Confirmation Hands-on (All levels)
Moderator: Bruno C. Odisio, MD, PhD, FSIR, MD Anderson Cancer Center
Faculty: Iwan Paolucci, PhD, D Anderson Cancer Center; Francois H. Cornelis, MD, PhD, Memorial Sloan Kettering Cancer Center; Keith M. Horton, MD, FSIR, MedStar Health/Georgetown University School of Medicine; Luigi A.Solbiati, MD, Humanitas University and Research Hospital; Stephen J. Hunt, MD, PhD, FSIR, University of Pennsylvania; Brian Park, MD, OHSU; Alex King, MBBS, MRCS, FRCR, University Hospitals Southampton; Sean Merrill Tutton, MD, UCSD Health
|
2:45 - 3:30 p.m. |
Exhibit Hall Coffee Break |
Discovery Theatre Programming
- 2:45 - 3:15 p.m. - IO in OBL (All levels)
- David Sperling, MD, FSIR, Columbia University Irving Medical Center; Scott Genshaft, MD, UCLA; Jayson S. Brower, MD, Inland Imaging
- 3:15 - 3:30 p.m. - Product Theatre
|
3:45 - 4:45 p.m. |
SIO Grants (200)
Moderators: Julius Chapiro, MD, PhD, Yale University School of Medicine; Christopher D. Malone, MD, Mallinckrodt Institute of Radiology, Washington University School of Medicine
- 2023 Grant Update: Spatial proteogenomics for prediction of response in combined radioembolization and immunotherapy of HCC, Elif Öcal, MD, LMU
- 2022 Grant Update: Stoking an Anti-Liver Cancer Immune Response with Cryoablation Plus Intratumoral Immunostimulant, Isabel Gala Newton, MD, PhD, VASDMC and UCSD
- 2022 Grant Update: Engineered Extracellular Vesicles to Modulate Immunotherapy in Liver Cancer, Kiyoyuki Minamiguchi, MD, PhD, Nara Medical University
- 2022 Grant Update: Single Cell Analysis of Combined Thermal Ablation and Immunotherapy of HCC, S. Nahum Goldberg, MD, Beth Israel Deaconess Medical Center/Harvard Medical School
- 2022 Grant Update: Immunobiologic and Metabolic Determinants of Response to Combination Locoregional and Immunotherapy in HCC, David Tischfield, MD, PhD, University of Pennsylvania
- Interactive Debate, All
|
Melanoma (200)
Moderators: David J. Eschelman, MD, FSIR, Sidney Kimmel Medical College of Thomas Jefferson University, Thomas Jefferson University Hospital; Gloria Hwang, MD, FSIR, Stanford University
- Building a Multidisciplinary Melanoma Program, Robert Adamo, MD, Thomas Jefferson University Hospital
- Relative Advantages of Chemoembolization and Immunoembolization, David J. Eschelman, MD, FSIR, Sidney Kimmel Medical College of Thomas Jefferson University, Thomas Jefferson University Hospital
- Y90 with or without Immunotherapy, Gloria Hwang, MD, FSIR, Stanford University
- Ablative Techniques with or without Immunotherapy, Chenyang Zhan, MD, PhD, Memorial Sloan Kettering Cancer Center
- Delcath, Alexander Villalobos, MD, University of North Carolina Chapel Hill
|
Hands-on Y90 Dosimetry Block 2* (200)
*Pre-registration is required to secure a workstation, at no additional fee. Participants will work in pairs to apply contouring principles for practical application. This session will use the Simplicit90Y software as a primary example. Registrants are strongly encouraged to attend both blocks for a well-rounded educational experience. Additional space will be available for observers based on room capacity.
Moderator: Juan Martin Gimenez, MD, Ocshner Health;
Faculty: Tyler Sandow, MD, Ocshner Health; David S. Wang, MD, FSIR, Stanford Medicine; Osman Ahmed, MD, University of Chicago; Beau Toskich, MD, Mayo Clinic; Diana Dinh, MD, MPH, Beth Israel Deaconess Medical Center; Marnix Lam, MD, PhD, University Medical Center Utrecht
|
5:00 - 6:00 p.m. |
Oligometastatic Disease Tumor Board (200)
Moderators: Martijn R. Meijerink, MD, PhD, FCIRSE, Amsterdam UMC; Alexios Kelekis, MD, PhD, EBIR, FCIRSE, FSIR, National and Kapodistrian University of Athens; A. Nick Kurup, MD, Mayo Clinic
Panelists: Afshin Gangi, MD, PhD, University Hospital Strasbourg, King’s College London; Terence Friedlander, MD, University of California San Francisco; Mekhail Anwar, MD, PhD, UC San Franscico and UC Berkeley
|
7:00 - 10:00 p.m. |
Sunday Soiree* at Alexxa's Las Vegas
*Attendance requires an additional fee.
|